ECSP16095540A - Composiciones antimicrobianas con agentes efervescentes - Google Patents

Composiciones antimicrobianas con agentes efervescentes

Info

Publication number
ECSP16095540A
ECSP16095540A ECIEPI201695540A ECPI201695540A ECSP16095540A EC SP16095540 A ECSP16095540 A EC SP16095540A EC IEPI201695540 A ECIEPI201695540 A EC IEPI201695540A EC PI201695540 A ECPI201695540 A EC PI201695540A EC SP16095540 A ECSP16095540 A EC SP16095540A
Authority
EC
Ecuador
Prior art keywords
compositions
antimicrobial compositions
effervescent agents
effervescent
treat
Prior art date
Application number
ECIEPI201695540A
Other languages
English (en)
Inventor
Danping Li
Original Assignee
Ferretti Antonio C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54868661&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP16095540(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferretti Antonio C filed Critical Ferretti Antonio C
Publication of ECSP16095540A publication Critical patent/ECSP16095540A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se relaciona con composiciones farmacéuticas que comprenden un agente antimicrobiano derivado de ácido quinolona carboxílico y un agente efervescente. Estas composiciones tienen tolerabilidad gastrointestinal mejorada y/o menos probabilidades de causar efectos secundarios gastrointestinales. Estas composiciones son útiles para la administración oral, para tratar, prevenir, o reducir el riesgo de infecciones microbianas.
ECIEPI201695540A 2014-06-20 2016-12-20 Composiciones antimicrobianas con agentes efervescentes ECSP16095540A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462014786P 2014-06-20 2014-06-20

Publications (1)

Publication Number Publication Date
ECSP16095540A true ECSP16095540A (es) 2017-03-31

Family

ID=54868661

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI201695540A ECSP16095540A (es) 2014-06-20 2016-12-20 Composiciones antimicrobianas con agentes efervescentes

Country Status (32)

Country Link
US (2) US20150366857A1 (es)
EP (3) EP3581180B1 (es)
JP (2) JP6995479B2 (es)
CN (2) CN106572982B9 (es)
AR (1) AR100920A1 (es)
AU (3) AU2015276954B2 (es)
BR (1) BR112016029761B1 (es)
CA (1) CA2952950C (es)
CL (2) CL2016003273A1 (es)
CR (2) CR20200565A (es)
CY (2) CY1121995T1 (es)
DK (2) DK3157510T3 (es)
EA (1) EA034152B1 (es)
EC (1) ECSP16095540A (es)
ES (2) ES2897576T3 (es)
HR (2) HRP20191133T1 (es)
HU (2) HUE044764T2 (es)
IL (1) IL249622A0 (es)
LT (2) LT3157510T (es)
MX (2) MX386171B (es)
PE (2) PE20170304A1 (es)
PH (2) PH12016502548B1 (es)
PL (2) PL3157510T3 (es)
PT (2) PT3157510T (es)
RS (2) RS62538B1 (es)
SI (2) SI3581180T1 (es)
SM (2) SMT202100618T1 (es)
SV (1) SV2016005349A (es)
TR (1) TR201909417T4 (es)
TW (2) TWI732337B (es)
UY (1) UY36184A (es)
WO (1) WO2015196027A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022240897A1 (en) * 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194617A (en) * 1988-12-17 1993-03-16 Meiji Seika Kaisha, Ltd. 2,3-disubstituted-4-hydroxyquinoline derivatives
US5223264A (en) * 1989-10-02 1993-06-29 Cima Labs, Inc. Pediatric effervescent dosage form
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
CA2290712C (en) 1995-09-22 2003-09-09 Wakunaga Pharmaceutical Co., Ltd. Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
DE69909801T2 (de) * 1998-09-14 2004-06-03 Ranbaxy Laboratories, Ltd. Oral verabreichtes system zur zeitlich und räumlich gesteuerten arzneistoffabgabe
US6187317B1 (en) * 1999-07-14 2001-02-13 Judith Taylor Natural anti-diarrheal composition and method
US6414036B1 (en) * 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
JP2005097116A (ja) 1999-11-11 2005-04-14 Wakunaga Pharmaceut Co Ltd キノリンカルボン酸誘導体アルカリ金属塩及びこれを用いたキノリンカルボン酸誘導体の精製法
US7157100B2 (en) * 2002-06-04 2007-01-02 J.B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical composition for controlled drug delivery system
EP2816033A1 (en) 2004-07-30 2014-12-24 Abbvie Inc. Preparation of pyridonecarboxylic acid antibacterials
ES2901955T3 (es) * 2004-10-08 2022-03-24 Abbvie Inc Sal meglumínica y formas cristalinas de la misma de un farmaco (delafloxacina)
EP2522365B1 (en) * 2004-11-24 2016-10-26 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
EP2286800A1 (en) * 2005-04-11 2011-02-23 Abbott Laboratories Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs
DE602005007205D1 (de) * 2005-07-19 2008-07-10 Ethypharm Sa Gastroretentive Zusammensetzungen und Verfahren zur Herstellung
US7611739B2 (en) * 2006-01-06 2009-11-03 Amerilab Technologies, Inc. Method of using guava extract and composition including guava extract
WO2008021256A2 (en) * 2006-08-11 2008-02-21 Aqua Resources Corporation Nanoplatelet metal hydroxides and methods of preparing same
CN1943561A (zh) * 2006-08-23 2007-04-11 北京阜康仁生物制药科技有限公司 普卢利沙星口腔崩解片及其制备方法
NZ598728A (en) * 2006-12-22 2013-09-27 Ironwood Pharmaceuticals Inc Compositions comprising bile acid sequestrants for treating esophageal disorders
NZ580972A (en) * 2007-06-04 2012-02-24 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
EP2373166A4 (en) * 2008-11-15 2014-11-05 Rib X Pharmaceuticals Inc ANTIMICROBIAL COMPOSITIONS
WO2010096551A2 (en) * 2009-02-18 2010-08-26 Rib-X Pharmaceuticals, Inc. Antimicrobial compositions
GB201020076D0 (en) * 2010-11-26 2011-01-12 Liverpool School Tropical Medicine Antimalarial compounds
KR20180080358A (ko) * 2011-01-10 2018-07-11 인피니티 파마슈티칼스, 인코포레이티드 이소퀴놀린온 및 이의 고체 형태의 제조 방법
CA2824403C (en) * 2011-01-14 2019-09-24 Vertex Pharmaceuticals Incorporated Solid forms of gyrase inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea
JP2013034468A (ja) * 2011-08-10 2013-02-21 Nisshin Sugar Mfg Co Ltd 発泡成型甘味料
WO2013090891A1 (en) * 2011-12-16 2013-06-20 Celanese Eva Performance Polymers, Inc. Controlled release vehicles having desired void volume architectures
CN102697751A (zh) * 2012-05-30 2012-10-03 河南牧翔动物药业有限公司 一种畜禽专用恩诺沙星泡腾分散片及其制备方法

Also Published As

Publication number Publication date
EP3157510A4 (en) 2018-02-21
AU2020256457B2 (en) 2021-09-30
EP3581180B1 (en) 2021-08-04
CY1125395T1 (el) 2023-03-24
SI3157510T1 (sl) 2019-09-30
CN106572982A (zh) 2017-04-19
TR201909417T4 (tr) 2019-07-22
MX386171B (es) 2025-03-18
CA2952950C (en) 2023-11-14
LT3157510T (lt) 2019-09-25
MX2016017350A (es) 2017-04-06
PH12016502548B1 (en) 2023-05-24
RS62538B1 (sr) 2021-12-31
CN114831955B (zh) 2024-03-12
EP3157510A1 (en) 2017-04-26
CR20160592A (es) 2017-02-21
CR20200565A (es) 2021-01-14
TWI705814B (zh) 2020-10-01
SV2016005349A (es) 2017-08-31
PH12016502548A1 (en) 2017-04-10
PL3581180T3 (pl) 2022-02-07
DK3157510T3 (da) 2019-07-01
CN106572982B (zh) 2022-06-03
AU2015276954B2 (en) 2020-07-23
EP3581180A1 (en) 2019-12-18
AU2015276954A1 (en) 2017-01-12
EA034152B1 (ru) 2020-01-09
CA2952950A1 (en) 2015-12-23
HRP20211685T1 (hr) 2022-02-04
AU2020256457A1 (en) 2020-11-12
SMT202100618T1 (it) 2022-01-10
CY1121995T1 (el) 2020-10-14
SMT201900348T1 (it) 2019-09-09
RS59064B1 (sr) 2019-08-30
LT3581180T (lt) 2021-12-27
TW202005650A (zh) 2020-02-01
EP3919057A1 (en) 2021-12-08
IL249622A0 (en) 2017-02-28
JP6995479B2 (ja) 2022-01-14
MX2019012608A (es) 2019-12-02
US20200237744A1 (en) 2020-07-30
PL3157510T3 (pl) 2019-12-31
JP7149991B2 (ja) 2022-10-07
ES2732865T3 (es) 2019-11-26
EP3157510B1 (en) 2019-03-27
PE20210927A1 (es) 2021-05-19
EP3919057B1 (en) 2026-01-28
US20150366857A1 (en) 2015-12-24
UY36184A (es) 2016-01-29
TW201625249A (zh) 2016-07-16
BR112016029761A2 (pt) 2017-08-22
SI3581180T1 (sl) 2021-12-31
CL2016003273A1 (es) 2017-08-04
AU2021286284A1 (en) 2022-01-06
ES2897576T3 (es) 2022-03-01
NZ727638A (en) 2023-08-25
JP2017518349A (ja) 2017-07-06
PT3581180T (pt) 2021-11-09
CL2020003153A1 (es) 2021-06-25
TWI732337B (zh) 2021-07-01
PE20170304A1 (es) 2017-04-19
EA201692532A1 (ru) 2017-05-31
HRP20191133T1 (hr) 2019-09-20
HUE044764T2 (hu) 2019-11-28
DK3581180T3 (da) 2021-11-08
PH12022550979A1 (en) 2023-06-26
MX368940B (es) 2019-10-21
CN114831955A (zh) 2022-08-02
CN106572982B9 (zh) 2022-07-08
BR112016029761B1 (pt) 2023-03-07
WO2015196027A1 (en) 2015-12-23
PT3157510T (pt) 2019-06-21
AR100920A1 (es) 2016-11-09
BR112016029761A8 (pt) 2021-06-29
HUE056298T2 (hu) 2022-02-28
AU2021286284B2 (en) 2024-02-29
JP2020183415A (ja) 2020-11-12

Similar Documents

Publication Publication Date Title
CL2018001349A1 (es) Composiciones que comprenden cepas bacterianas
CL2018001367A1 (es) Composiciones que comprenden cepas bacterianas
EP3331547A4 (en) COMPOSITIONS WITH PERMEATION PROMOTERS FOR ACTIVE INJECTION
MX2015010139A (es) Composicion antiseptica oral para tratamiento de mucositis oral.
SV2011003907A (es) Composiciones antimicrobianas
PE20150199A1 (es) Composiciones farmaceuticas y tratamiento de mastitis
BR112016024235A2 (pt) composições farmacêuticas compreendendo agentes antibacterianos
MX373177B (es) Métodos de tratamiento de disquinesia y trastornos relacionados.
CL2020003153A1 (es) Composiciones antimicrobianas con agentes efervescentes (divisional de solicitud n° 03273-2016)
BR112018007374A2 (pt) composição farmacêutica
BR112017014295A2 (pt) composição farmacêutica.
BR112016024236A2 (pt) composições farmacêuticas compreendendo agentes antibacterianos
MX360040B (es) Nuevo agente antibacteriano derivado de florfenicol unido a sulfoximina y el uso del mismo en el tratamiento de infecciones bacterianas en ganado vacuno.
CL2016003271A1 (es) Métodos para tratar infecciones
MX350565B (es) Composiciones farmaceuticas.
MX2019007390A (es) Peptidos antimicrobianos y usos de los mismos.
CR20160591A (es) Metodos para tratar infecciones
UA101533U (uk) Полівалентний оральний гель для лікування і профілактики післяімплантаційних ускладнень
UA91125U (uk) Антибактеріальна композиція